Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hangxiang Wang

Showing results (21-30 of 101) with videos related to

Pageof 11
Sort By:
Cancer Research|July 11, 2024
Ionizable STING-Activating Nanoadjuvants Enhance Tumor Immunogenicity and Potentiate Immunotherapy Efficacy in Solid TumorsShiyun Xian, Xiaona Chen, Sihang Ren, et al.
Drug Delivery|March 2, 2023
Oral liposomal delivery of an activatable budesonide prodrug reduces colitis in experimental miceShiyun Xian, Jiabin Zhu, Yuchen Wang, et al.
Acta Biomaterialia|July 18, 2025
Mitochondria-targeting pseudo-stealthy nanophotosensitizer as a potent immunogenic cell death inducer to unleash the cancer-immunity cycle for melanoma therapyKewei Shi, Zichong Ye, Hengyan Zhu, et al.
International Journal of Pharmaceutics|March 1, 2021
Repurposing of camptothecin: An esterase-activatable prodrug delivered by a self-emulsifying formulation that improves efficacy in colorectal cancerTao Fang, Zhijian Ye, Xiaona Chen, et al.
Nanoscale Horizons|November 19, 2020
Self-assembling a natural small molecular inhibitor that shows aggregation-induced emission and potentiates antitumor efficacyXiaona Chen, Zhen Hu, Liqian Zhou, et al.
Frontiers in Bioengineering and Biotechnology|July 26, 2021
Orally Administrable Therapeutic Nanoparticles for the Treatment of Colorectal CancerKangkang Ying, Bingjun Bai, Xing Gao, et al.
Acta Biomaterialia|June 4, 2021
A general prodrug nanohydrogel platform for reduction-triggered drug activation and treatment of taxane-resistant malignanciesJie Yao, Tongyu Li, Xiaowei Shi, et al.
Theranostics|March 23, 2021
Balancing the stability and drug activation in adaptive nanoparticles potentiates chemotherapy in multidrug-resistant cancerJianqin Wan, Lingling Huang, Jiangting Cheng, et al.
Acta Biomaterialia|November 21, 2024
A self-assembling cytotoxic nanotherapeutic strategy for high drug loading and synergistic delivery of molecularly targeted therapiesZhelong Zhang, Hengyan Zhu, Ke Xie, et al.
Biomaterials Research|November 4, 2024
Hybrid Homodimeric Prodrug Nanoassemblies for Low-Toxicity and Synergistic Chemophotodynamic Therapy of MelanomaPeirong Xu, Fanchao Meng, Jianqin Wan, et al.
Pageof 11

Showing results (21-30 of 101) with videos related to

Sort By:
Pageof 11
Cancer Research|July 11, 2024
Ionizable STING-Activating Nanoadjuvants Enhance Tumor Immunogenicity and Potentiate Immunotherapy Efficacy in Solid TumorsShiyun Xian, Xiaona Chen, Sihang Ren, et al.
Drug Delivery|March 2, 2023
Oral liposomal delivery of an activatable budesonide prodrug reduces colitis in experimental miceShiyun Xian, Jiabin Zhu, Yuchen Wang, et al.
Acta Biomaterialia|July 18, 2025
Mitochondria-targeting pseudo-stealthy nanophotosensitizer as a potent immunogenic cell death inducer to unleash the cancer-immunity cycle for melanoma therapyKewei Shi, Zichong Ye, Hengyan Zhu, et al.
International Journal of Pharmaceutics|March 1, 2021
Repurposing of camptothecin: An esterase-activatable prodrug delivered by a self-emulsifying formulation that improves efficacy in colorectal cancerTao Fang, Zhijian Ye, Xiaona Chen, et al.
Nanoscale Horizons|November 19, 2020
Self-assembling a natural small molecular inhibitor that shows aggregation-induced emission and potentiates antitumor efficacyXiaona Chen, Zhen Hu, Liqian Zhou, et al.
Frontiers in Bioengineering and Biotechnology|July 26, 2021
Orally Administrable Therapeutic Nanoparticles for the Treatment of Colorectal CancerKangkang Ying, Bingjun Bai, Xing Gao, et al.
Acta Biomaterialia|June 4, 2021
A general prodrug nanohydrogel platform for reduction-triggered drug activation and treatment of taxane-resistant malignanciesJie Yao, Tongyu Li, Xiaowei Shi, et al.
Theranostics|March 23, 2021
Balancing the stability and drug activation in adaptive nanoparticles potentiates chemotherapy in multidrug-resistant cancerJianqin Wan, Lingling Huang, Jiangting Cheng, et al.
Acta Biomaterialia|November 21, 2024
A self-assembling cytotoxic nanotherapeutic strategy for high drug loading and synergistic delivery of molecularly targeted therapiesZhelong Zhang, Hengyan Zhu, Ke Xie, et al.
Biomaterials Research|November 4, 2024
Hybrid Homodimeric Prodrug Nanoassemblies for Low-Toxicity and Synergistic Chemophotodynamic Therapy of MelanomaPeirong Xu, Fanchao Meng, Jianqin Wan, et al.
Pageof 11